825 related articles for article (PubMed ID: 20022856)
1. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
[TBL] [Abstract][Full Text] [Related]
2. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
Cengiz C; Ardicoglu Y; Bulut S; Boyacioglu S
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):813-9. PubMed ID: 19820404
[TBL] [Abstract][Full Text] [Related]
3. Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease.
Boyraz M; Cekmez F; Karaoglu A; Cinaz P; Durak M; Bideci A
Biomark Med; 2013 Oct; 7(5):737-45. PubMed ID: 24044566
[TBL] [Abstract][Full Text] [Related]
4. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
5. Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
Fenkci S; Rota S; Sabir N; Akdag B
Eur J Med Res; 2007 Feb; 12(2):68-73. PubMed ID: 17369120
[TBL] [Abstract][Full Text] [Related]
6. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents.
Ciba I; Widhalm K
Acta Paediatr; 2007 Jan; 96(1):109-12. PubMed ID: 17187615
[TBL] [Abstract][Full Text] [Related]
7. Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels.
Jiang LL; Li L; Hong XF; Li YM; Zhang BL
Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):662-6. PubMed ID: 19282764
[TBL] [Abstract][Full Text] [Related]
8. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children.
Zou CC; Liang L; Hong F; Fu JF; Zhao ZY
Endocr J; 2005 Oct; 52(5):519-24. PubMed ID: 16284427
[TBL] [Abstract][Full Text] [Related]
9. Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease.
Abenavoli L; Luigiano C; Guzzi PH; Milic N; Morace C; Stelitano L; Consolo P; Miraglia S; Fagoonee S; Virgilio C; Luzza F; De Lorenzo A; Pellicano R
Panminerva Med; 2014 Jun; 56(2):189-93. PubMed ID: 24994581
[TBL] [Abstract][Full Text] [Related]
10. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.
Pagano C; Soardo G; Pilon C; Milocco C; Basan L; Milan G; Donnini D; Faggian D; Mussap M; Plebani M; Avellini C; Federspil G; Sechi LA; Vettor R
J Clin Endocrinol Metab; 2006 Mar; 91(3):1081-6. PubMed ID: 16394091
[TBL] [Abstract][Full Text] [Related]
11. Factors related to non-alcoholic fatty liver disease in obese children.
Eminoğlu TF; Camurdan OM; Oktar SO; Bideci A; Dalgiç B
Turk J Gastroenterol; 2008 Jun; 19(2):85-91. PubMed ID: 19110662
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor alpha and its soluble receptors in obese children with NAFLD.
Lebensztejn DM; Kowalczuk D; Tarasów E; Skiba E; Kaczmarski M
Adv Med Sci; 2010; 55(1):74-9. PubMed ID: 20371430
[TBL] [Abstract][Full Text] [Related]
13. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between serum adiponectin level and serum alanine aminotransferase elevation in Korean male with nonalcoholic fatty liver disease].
Lee YS; Cho YK; Pae JC; Oh SY; Kang MS; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Lee WY; Oh KW; Yun EJ; Oh ES
Korean J Hepatol; 2006 Jun; 12(2):221-9. PubMed ID: 16804347
[TBL] [Abstract][Full Text] [Related]
15. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.
de Piano A; de Mello MT; Sanches Pde L; da Silva PL; Campos RM; Carnier J; Corgosinho F; Foschini D; Masquio DL; Tock L; Oyama LM; do Nascimento CM; Tufik S; Dâmaso AR
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1313-24. PubMed ID: 22932160
[TBL] [Abstract][Full Text] [Related]
17. Plasma adiponectin is decreased in nonalcoholic fatty liver disease.
Pagano C; Soardo G; Esposito W; Fallo F; Basan L; Donnini D; Federspil G; Sechi LA; Vettor R
Eur J Endocrinol; 2005 Jan; 152(1):113-8. PubMed ID: 15762194
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children.
Koot BG; van der Baan-Slootweg OH; Bohte AE; Nederveen AJ; van Werven JR; Tamminga-Smeulders CL; Merkus MP; Schaap FG; Jansen PL; Stoker J; Benninga MA
Obesity (Silver Spring); 2013 Mar; 21(3):583-90. PubMed ID: 23592667
[TBL] [Abstract][Full Text] [Related]
19. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of serum visfatin concentrations in children with nonalcoholic fatty liver disease].
Romanowska A; Lebensztejn DM
Pol Merkur Lekarski; 2010 Jun; 28(168):459-61. PubMed ID: 20642104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
